Patricia M Salmon, MD
Endocrinology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 27
- 6 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
27 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Salmon’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
27 of 27 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A110270 · Current
Licensed to practise in California · since 2009 · expires 2027-08-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$36,398
Medicare paid this office $36,398 for 187 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 82 | $17,686 | $80 |
| Short return visit (20+ min) | 99 | $12,305 | $53 |
| New patient visit (45+ min) | 12 | $1,317 | $110 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $1,236 | $43 |
| New patient visit (30+ min) | 20 | $1,167 | $58 |
Who their Medicare patients are
187 Original Medicare patients in 2024. Average age 71 · Under 65 19% · 85 and older 11% · Women 66% · Also on Medicaid 78% · Health risk score 1.94. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 70% · Chronic kidney disease 40% · Coronary heart disease 25% · Depression 23% · Heart failure 21% · Cancer 15% · Dementia 14% · COPD 13% · Atrial fibrillation 12% · Stroke 12%.
The office billed $336,020, Medicare allowed $50,456 and paid $36,398; for 561 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 187 | 561 | 71 | 1.94 | $336,020 | $36,398 |
| 2023 | 188 | 476 | 71 | 1.73 | $252,582 | $29,354 |
| 2022 | 153 | 418 | 71 | 1.81 | $198,375 | $24,761 |
| 2021 | 126 | 277 | 70 | 2.38 | $123,326 | $18,674 |
| 2020 | 196 | 405 | 70 | 2.10 | $161,122 | $24,589 |
| 2019 | 324 | 791 | 69 | 2.05 | $358,644 | $42,837 |
| 2018 | 261 | 594 | 68 | 1.91 | $259,081 | $31,396 |
| 2017 | 275 | 672 | 67 | 1.92 | $272,471 | $33,164 |
| 2016 | 293 | 603 | 67 | 1.90 | $191,754 | $33,316 |
| 2015 | 188 | 432 | 68 | 2.23 | $114,943 | $25,365 |
| 2014 | 183 | 388 | 67 | 1.82 | $96,863 | $22,723 |
| 2013 | 78 | 120 | 66 | 1.81 | $27,185 | $8,060 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 122 | $12,462 | $53 |
| Return visit (30+ min) | 64 | $10,470 | $81 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $2,190 | $47 |
| Short return visit | 23 | $752 | $29 |
2022: 6 services
| Short return visit (20+ min) | 106 | $12,450 | $55 |
| Return visit (30+ min) | 43 | $5,925 | $85 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $1,409 | $45 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,187 | $99 |
| Short return visit | 27 | $738 | $25 |
| Telephone medical discussion with physician, 5-10 minutes | 17 | $402 | $21 |
2021: 6 services
| Short return visit (20+ min) | 51 | $5,173 | $60 |
| Return visit (30+ min) | 31 | $4,071 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 29 | $3,258 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,522 | $76 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,796 | $106 |
| Telephone medical discussion with physician, 5-10 minutes | 23 | $738 | $28 |
2020: 8 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 73 | $7,555 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $6,264 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 48 | $3,802 | $46 |
| Return visit (30+ min) | 35 | $2,294 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,480 | $74 |
| Short return visit (20+ min) | 20 | $1,111 | $43 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $913 | $42 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $862 | $21 |
2019: 5 services
| Return visit (30+ min) | 102 | $15,839 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $10,744 | $65 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 103 | $9,297 | $88 |
| Short return visit (20+ min) | 72 | $3,942 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 47 | $920 | $8 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $11,113 | $65 |
| Return visit (30+ min) | 90 | $9,785 | $56 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 70 | $6,072 | $82 |
| Short return visit (20+ min) | 40 | $1,828 | $38 |
| New patient visit (45+ min) | 22 | $1,500 | $68 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 55 | $517 | $6 |
2017: 6 services
| Return visit (30+ min) | 90 | $12,053 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $9,558 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 64 | $5,584 | $82 |
| Short return visit (20+ min) | 66 | $3,531 | $36 |
| New patient visit (30+ min) | 12 | $790 | $66 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 63 | $681 | $6 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 57 | $10,271 | $63 |
| Return visit (30+ min) | 92 | $9,299 | $61 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 99 | $8,974 | $87 |
| Short return visit (20+ min) | 62 | $2,514 | $36 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $1,470 | $34 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $381 | $7 |
| Photography of the retina | 13 | $93 | $7 |
2015: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $9,593 | $62 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 76 | $6,398 | $82 |
| Return visit (30+ min) | 59 | $5,575 | $61 |
| Short return visit (20+ min) | 49 | $2,262 | $36 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $985 | $31 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $6,981 | $64 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 64 | $5,910 | $87 |
| Short return visit (20+ min) | 62 | $3,591 | $40 |
| Return visit (30+ min) | 31 | $2,588 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,582 | $122 |
| Short return visit | 27 | $541 | $17 |
2013: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,603 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,048 | $62 |
| Short return visit (20+ min) | 29 | $1,431 | $43 |
| Return visit (30+ min) | 18 | $1,255 | $66 |
Medicaid work
$30,877 in 2024
Medicaid paid $30,877 for 5,754 billed services this clinician did in 2024, up to 138 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 845 | $15,318 |
| Short return visit (20+ min) | 960 | $15,311 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 13 | $247 |
| Medication list documented in medical record (COA) | 1,049 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 30 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 783 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 375 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 305 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 948 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 383 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 63 | $0 |
| 2024 | 5,754 | 11 | 138 | $30,877 |
| 2023 | 2,360 | 13 | 116 | $12,916 |
| 2022 | 1,560 | 3 | 112 | $12,478 |
| 2021 | 869 | 3 | 67 | $8,622 |
| 2020 | 460 | 5 | 42 | $6,915 |
| 2019 | 2,790 | 12 | 87 | $25,768 |
| 2018 | 2,943 | 16 | 90 | $23,110 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 1,134 | $7,309 |
| Return visit (30+ min) | 566 | $5,162 |
| Service | 12 | $409 |
| Short return visit | 12 | $36 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 49 | $0 |
| HEMOGLOBIN A1C LEVEL >9.0% | 40 | $0 |
| Most recent hemoglobin A1c (HbA1c) level greater than or equal to 7.0% and less than 8.0% (DM) | 42 | $0 |
| Most recent hemoglobin A1c (HbA1c) level greater than or equal to 8.0% and less than or equal to 9.0% (DM) | 29 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 131 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 46 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 49 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 199 | $0 |
2022
| Short return visit (20+ min) | 1,059 | $8,074 |
| Return visit (30+ min) | 285 | $3,082 |
| Short return visit | 216 | $1,322 |
2021
| Short return visit (20+ min) | 525 | $5,568 |
| Short return visit | 233 | $2,413 |
| Return visit (30+ min) | 111 | $641 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 142 | $3,156 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 114 | $1,580 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 52 | $1,036 |
| Return visit (30+ min) | 98 | $922 |
| Short return visit (20+ min) | 54 | $221 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 451 | $7,527 |
| Return visit (30+ min) | 907 | $6,556 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 160 | $2,646 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 206 | $2,517 |
| Short return visit (20+ min) | 365 | $1,626 |
| Hemoglobin A1C level | 122 | $1,342 |
| Service | 33 | $1,091 |
| Blood glucose (sugar) level | 176 | $865 |
| Thyroid stimulating hormone (TSH) | 41 | $762 |
| OFF/OP EST MAY X REQ PHY/QHP | 291 | $543 |
| New patient visit (45+ min) | 14 | $271 |
| Creatinine; blood | 24 | $23 |
2018
| Return visit (30+ min) | 858 | $6,613 |
| Medical nutrition therapy; initial assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 317 | $3,132 |
| Hemoglobin A1C level | 262 | $2,871 |
| Service | 52 | $1,773 |
| Blood glucose (sugar) level | 371 | $1,771 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 189 | $1,668 |
| Short return visit (20+ min) | 295 | $1,615 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 127 | $1,465 |
| Thyroid stimulating hormone (TSH) | 57 | $1,066 |
| OFF/OP EST MAY X REQ PHY/QHP | 314 | $573 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 13 | $211 |
| Albumin; urine (eg, microalbumin), quantitative | 18 | $118 |
Drugs they prescribed that Part D paid
$1,020,917
Pharmacies billed $1,020,917 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,537) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
556 generic and 849 brand-name prescriptions · $1,020,917 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Signifor Lar | 13 | $243,179 | $18,706 |
| Ozempic | 138 | $151,427 | $1,097 |
| Jardiance | 71 | $77,621 | $1,093 |
| Evenity (2 Syringes) | 33 | $74,262 | $2,250 |
| Prolia | 44 | $66,485 | $1,511 |
See all 40 drugs
| Signifor Lar | 13 | $243,179 | $18,706 |
| Ozempic | 138 | $151,427 | $1,097 |
| Jardiance | 71 | $77,621 | $1,093 |
| Evenity (2 Syringes) | 33 | $74,262 | $2,250 |
| Prolia | 44 | $66,485 | $1,511 |
| Trulicity | 58 | $61,240 | $1,056 |
| Tymlos | 18 | $44,977 | $2,499 |
| Phenoxybenzamine | 13 | $35,184 | $2,706 |
| Januvia | 21 | $25,139 | $1,197 |
| Teriparatide | 13 | $23,924 | $1,840 |
| Toujeo Max Solostar | 13 | $19,198 | $1,477 |
| Semglee (Yfgn) | 39 | $18,935 | $486 |
| Synjardy Xr | 11 | $13,383 | $1,217 |
| Humulin R U-500 Kwikpen | 12 | $12,857 | $1,071 |
| Basaglar Kwikpen U-100 | 30 | $10,658 | $355 |
| Tresiba Flextouch U-100 | 27 | $10,628 | $394 |
| Fiasp Flextouch | 18 | $9,043 | $502 |
| Praluent | 13 | $6,310 | $485 |
| Ultra-Fine Short Pen Needle | 44 | $5,762 | $131 |
| Insulin Aspart Flexpen | 23 | $4,933 | $214 |
| Lantus Solostar | 41 | $3,207 | $78 |
| Humalog Kwikpen U-100 | 17 | $2,885 | $170 |
| Novolog Flexpen | 17 | $2,501 | $147 |
| Hydrocortisone | 50 | $2,267 | $45 |
| Ultra-Fine Mini Pen Needle | 29 | $1,852 | $64 |
| Ultra-Fine Nano Pen Needle | 17 | $1,618 | $95 |
| Levothyroxine | 162 | $1,521 | $9 |
| Synthroid | 11 | $1,385 | $126 |
| Insulin Lispro Kwikpen U-100 | 13 | $1,095 | $84 |
| Methimazole | 70 | $885 | $13 |
| Cinacalcet | 11 | $690 | $63 |
| Metformin | 93 | $594 | $6 |
| Calcitriol | 12 | $589 | $49 |
| Glipizide | 30 | $463 | $15 |
| Insulin | 11 | $460 | $42 |
| Testosterone Cypionate | 11 | $425 | $39 |
| Alendronate | 34 | $208 | $6 |
| Metformin Hcl Er | 17 | $128 | $8 |
| Atorvastatin | 16 | $111 | $7 |
| Rosuvastatin | 13 | $98 | $8 |
Year by year
| 2024 | 1,537 | 233 | 0% (0) | 55% | $1,020,917 |
| 2023 | 1,544 | 256 | 0% (0) | 58% | $1,120,769 |
| 2022 | 1,372 | 199 | 0% (0) | 59% | $810,146 |
| 2021 | 1,299 | 179 | 0% (0) | 64% | $716,280 |
| 2020 | 1,676 | 223 | 0% (0) | 56% | $892,106 |
| 2019 | 1,868 | 251 | None | 51% | $908,312 |
| 2018 | 1,712 | 244 | 0% (0) | 51% | $755,035 |
| 2017 | 1,653 | 256 | 0% (0) | 48% | $581,223 |
| 2016 | 1,051 | 207 | None | 40% | $292,684 |
| 2015 | 475 | 93 | 0% (0) | 34% | $74,279 |
| 2014 | 269 | 63 | 0% (0) | 36% | $41,759 |
| 2013 | 133 | 44 | 0% (0) | None | $26,080 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Trulicity | 126 | $149,073 | $1,183 |
| Forteo | 32 | $131,913 | $4,122 |
| Prolia | 59 | $93,867 | $1,591 |
| Ozempic | 78 | $86,281 | $1,106 |
| Jardiance | 70 | $85,603 | $1,223 |
| Phenoxybenzamine | 11 | $59,970 | $5,452 |
| Novolog Flexpen | 67 | $49,114 | $733 |
| Novolog | 22 | $34,848 | $1,584 |
| Humulin R U-500 Kwikpen | 23 | $30,250 | $1,315 |
| Tymlos | 11 | $29,489 | $2,681 |
| Toujeo Max Solostar | 18 | $27,098 | $1,505 |
| Tradjenta | 26 | $26,758 | $1,029 |
| Rybelsus | 18 | $24,406 | $1,356 |
| Basaglar Kwikpen U-100 | 50 | $22,235 | $445 |
| Lantus Solostar | 38 | $21,161 | $557 |
| Januvia | 12 | $17,078 | $1,423 |
| Cinacalcet | 16 | $13,495 | $843 |
| Tresiba Flextouch U-200 | 13 | $12,927 | $994 |
| Semglee (Yfgn) | 30 | $12,759 | $425 |
| Novolog Mix 70-30 Flexpen | 11 | $10,291 | $936 |
| Tresiba Flextouch U-100 | 21 | $10,262 | $489 |
| Synjardy Xr | 11 | $5,927 | $539 |
| Ultra-Fine Short Pen Needle | 41 | $4,761 | $116 |
| Ultra-Fine Mini Pen Needle | 40 | $3,874 | $97 |
| Levothyroxine | 127 | $3,247 | $26 |
| Hydrocortisone | 33 | $2,016 | $61 |
| Ultra-Fine Nano Pen Needle | 18 | $2,002 | $111 |
| Octreotide Acetate | 11 | $1,509 | $137 |
| Insulin | 17 | $1,264 | $74 |
| Metformin | 80 | $1,256 | $16 |
| Methimazole | 65 | $1,242 | $19 |
| Glipizide | 36 | $786 | $22 |
| Insulin | 13 | $597 | $46 |
| Metformin Hcl Er | 21 | $512 | $24 |
| Alendronate | 24 | $311 | $13 |
2022: 32 drugs
| Trulicity | 96 | $102,550 | $1,068 |
| Jardiance | 83 | $93,836 | $1,131 |
| Phenoxybenzamine | 13 | $75,976 | $5,844 |
| Novolog Flexpen | 74 | $55,725 | $753 |
| Ozempic | 37 | $45,679 | $1,235 |
| Prolia | 33 | $44,447 | $1,347 |
| Evenity (2 Syringes) | 22 | $41,106 | $1,868 |
| Lantus Solostar | 82 | $40,266 | $491 |
| Victoza 3-Pak | 29 | $33,143 | $1,143 |
| Novolog | 25 | $29,762 | $1,190 |
| Humulin R U-500 Kwikpen | 22 | $29,569 | $1,344 |
| Novolog Mix 70-30 Flexpen | 25 | $24,613 | $985 |
| Januvia | 17 | $23,394 | $1,376 |
| Tresiba Flextouch U-200 | 16 | $20,803 | $1,300 |
| Toujeo Max Solostar | 13 | $16,426 | $1,264 |
| Basaglar Kwikpen U-100 | 43 | $16,372 | $381 |
| Novolin 70-30 | 23 | $13,202 | $574 |
| Insulin Lispro Kwikpen U-100 | 12 | $6,414 | $535 |
| Ultra-Fine Mini Pen Needle | 53 | $5,997 | $113 |
| Ultra-Fine Short Pen Needle | 42 | $3,790 | $90 |
| Levothyroxine | 84 | $2,232 | $27 |
| Insulin | 25 | $1,993 | $80 |
| Hydrocortisone | 28 | $1,616 | $58 |
| Methimazole | 57 | $975 | $17 |
| Metformin | 78 | $777 | $10 |
| Testosterone Cypionate | 12 | $738 | $61 |
| Insulin | 12 | $507 | $42 |
| Metformin Hcl Er | 17 | $401 | $24 |
| Glipizide | 29 | $379 | $13 |
| Glipizide Er | 13 | $368 | $28 |
| Alendronate | 21 | $213 | $10 |
| Atorvastatin | 11 | $120 | $11 |
2021: 31 drugs
| Jardiance | 92 | $91,325 | $993 |
| Ozempic | 82 | $80,172 | $978 |
| Trulicity | 77 | $62,343 | $810 |
| Novolog Flexpen | 85 | $61,314 | $721 |
| Victoza 3-Pak | 36 | $44,764 | $1,243 |
| Lantus Solostar | 83 | $35,834 | $432 |
| Novolog Mix 70-30 Flexpen | 36 | $33,978 | $944 |
| Novolog | 19 | $32,786 | $1,726 |
| Tresiba Flextouch U-200 | 31 | $30,481 | $983 |
| Prolia | 22 | $27,853 | $1,266 |
| Basaglar Kwikpen U-100 | 33 | $17,333 | $525 |
| Januvia | 20 | $17,207 | $860 |
| Humalog | 11 | $12,991 | $1,181 |
| Novolin 70-30 | 28 | $9,467 | $338 |
| Tradjenta | 11 | $8,336 | $758 |
| Humulin N | 12 | $6,924 | $577 |
| Ultra-Fine Mini Pen Needle | 67 | $5,832 | $87 |
| Tresiba Flextouch U-100 | 12 | $5,736 | $478 |
| Ultra-Fine Short Pen Needle | 24 | $2,242 | $93 |
| Levothyroxine | 78 | $2,001 | $26 |
| Insulin | 24 | $1,539 | $64 |
| Comfort Ez Pen Needle | 13 | $1,231 | $95 |
| Hydrocortisone | 24 | $896 | $37 |
| Testosterone Cypionate | 12 | $895 | $75 |
| Methimazole | 44 | $627 | $14 |
| Insulin | 13 | $511 | $39 |
| Metformin Hcl Er | 35 | $474 | $14 |
| Glipizide Er | 15 | $336 | $22 |
| Metformin | 45 | $306 | $7 |
| Glipizide | 25 | $269 | $11 |
| Alendronate | 12 | $77 | $6 |
2020: 38 drugs
| Phenoxybenzamine | 13 | $121,425 | $9,340 |
| Novolog Flexpen | 88 | $83,290 | $946 |
| Ozempic | 71 | $69,325 | $976 |
| Jardiance | 71 | $64,848 | $913 |
| Forteo | 18 | $64,098 | $3,561 |
| Prolia | 31 | $37,519 | $1,210 |
| Lantus Solostar | 88 | $36,549 | $415 |
| Trulicity | 43 | $33,244 | $773 |
| Basaglar Kwikpen U-100 | 76 | $32,954 | $434 |
| Novolog | 27 | $31,153 | $1,154 |
| Januvia | 33 | $30,044 | $910 |
| Novolog Mix 70-30 Flexpen | 25 | $29,960 | $1,198 |
| Humalog | 23 | $26,276 | $1,142 |
| Victoza 2-Pak | 31 | $25,725 | $830 |
| Victoza 3-Pak | 26 | $22,085 | $849 |
| Lantus | 30 | $17,572 | $586 |
| Tresiba Flextouch U-200 | 13 | $16,467 | $1,267 |
| Tradjenta | 16 | $13,244 | $828 |
| Novolin 70-30 | 28 | $10,907 | $390 |
| Tresiba Flextouch U-100 | 16 | $7,835 | $490 |
| Ultra-Fine Mini Pen Needle | 85 | $6,605 | $78 |
| Humulin N | 15 | $6,475 | $432 |
| Testosterone | 12 | $5,501 | $458 |
| Levothyroxine | 130 | $3,837 | $30 |
| Vascepa | 12 | $3,753 | $313 |
| Ultra-Fine Short Pen Needle | 44 | $3,314 | $75 |
| Insulin | 35 | $2,546 | $73 |
| Desmopressin Acetate | 13 | $1,665 | $128 |
| Comfort Ez Pen Needle | 14 | $1,317 | $94 |
| Hydrocortisone | 38 | $1,275 | $34 |
| Testosterone Cypionate | 19 | $1,047 | $55 |
| Methimazole | 53 | $885 | $17 |
| Metformin | 89 | $673 | $8 |
| Glipizide | 75 | $661 | $9 |
| Insulin | 17 | $424 | $25 |
| Insulin | 11 | $396 | $36 |
| Metformin Hcl Er | 35 | $270 | $8 |
| Glipizide Er | 12 | $140 | $12 |
2019: 39 drugs
| Phenoxybenzamine | 13 | $126,209 | $9,708 |
| Novolog Flexpen | 107 | $99,251 | $928 |
| Forteo | 25 | $83,030 | $3,321 |
| Novolog Mix 70-30 Flexpen | 30 | $44,796 | $1,493 |
| Ozempic | 45 | $42,370 | $942 |
| Trulicity | 49 | $37,761 | $771 |
| Novolog | 40 | $37,399 | $935 |
| Humalog | 36 | $34,859 | $968 |
| Basaglar Kwikpen U-100 | 80 | $34,382 | $430 |
| Lantus Solostar | 82 | $34,105 | $416 |
| Prolia | 28 | $33,811 | $1,208 |
| Lantus | 52 | $33,746 | $649 |
| Jardiance | 45 | $32,695 | $727 |
| Januvia | 20 | $26,174 | $1,309 |
| Victoza 2-Pak | 29 | $20,771 | $716 |
| Humulin 70/30 Kwikpen | 15 | $16,347 | $1,090 |
| Novolin 70-30 | 21 | $10,714 | $510 |
| Ultra-Fine Mini Pen Needle | 137 | $9,621 | $70 |
| Testosterone | 19 | $8,895 | $468 |
| Humulin N | 23 | $7,772 | $338 |
| Levothyroxine | 119 | $3,671 | $31 |
| Desmopressin Acetate | 21 | $2,811 | $134 |
| Ultra-Fine Short Pen Needle | 35 | $2,768 | $79 |
| Comfort Ez Pen Needle | 27 | $2,472 | $92 |
| Insulin | 34 | $1,773 | $52 |
| Alcohol Pads | 14 | $1,328 | $95 |
| Hydrocortisone | 25 | $1,233 | $49 |
| Methimazole | 49 | $968 | $20 |
| Metformin | 102 | $946 | $9 |
| Glipizide | 120 | $909 | $8 |
| Insulin | 23 | $896 | $39 |
| Testosterone Cypionate | 11 | $574 | $52 |
| Veo Insulin | 12 | $369 | $31 |
| Glipizide Er | 19 | $335 | $18 |
| Insulin | 11 | $290 | $26 |
| Metformin Hcl Er | 23 | $218 | $9 |
| Simvastatin | 14 | $161 | $11 |
| Alendronate | 19 | $157 | $8 |
| Atorvastatin | 12 | $152 | $13 |
2018: 37 drugs
| Phenoxybenzamine | 13 | $109,478 | $8,421 |
| Novolog Flexpen | 86 | $96,131 | $1,118 |
| Forteo | 18 | $57,377 | $3,188 |
| Basaglar Kwikpen U-100 | 95 | $39,877 | $420 |
| Lantus | 69 | $36,717 | $532 |
| Lantus Solostar | 78 | $32,381 | $415 |
| Humalog | 46 | $31,341 | $681 |
| Farxiga | 19 | $24,575 | $1,293 |
| Novolog | 24 | $23,602 | $983 |
| Prolia | 20 | $22,982 | $1,149 |
| Novolin 70-30 | 42 | $21,681 | $516 |
| Januvia | 18 | $21,054 | $1,170 |
| Novolog Mix 70-30 Flexpen | 20 | $20,537 | $1,027 |
| Victoza 2-Pak | 25 | $13,992 | $560 |
| Humulin 70/30 Kwikpen | 15 | $13,093 | $873 |
| Humulin 70-30 | 16 | $12,874 | $805 |
| Trulicity | 16 | $11,216 | $701 |
| Jardiance | 16 | $8,669 | $542 |
| Ultra-Fine Mini Pen Needle | 110 | $8,598 | $78 |
| Tanzeum | 11 | $5,832 | $530 |
| Humulin N | 18 | $5,401 | $300 |
| Levothyroxine | 114 | $3,717 | $33 |
| Desmopressin Acetate | 26 | $3,655 | $141 |
| Vascepa | 11 | $2,899 | $264 |
| Insulin | 61 | $2,634 | $43 |
| Ultra-Fine Short Pen Needle | 31 | $2,345 | $76 |
| Hydrocortisone | 31 | $1,479 | $48 |
| Metformin | 111 | $961 | $9 |
| Insulin | 25 | $930 | $37 |
| Glipizide | 101 | $859 | $9 |
| Comfort Ez Pen Needle | 11 | $855 | $78 |
| Methimazole | 36 | $689 | $19 |
| Metformin Hcl Er | 11 | $237 | $22 |
| Atorvastatin | 12 | $205 | $17 |
| Alendronate | 18 | $135 | $7 |
| Simvastatin | 17 | $134 | $8 |
| Amlodipine Besylate | 14 | $113 | $8 |
2017: 34 drugs
| Forteo | 33 | $92,350 | $2,798 |
| Novolog Flexpen | 90 | $88,379 | $982 |
| Lantus Solostar | 115 | $45,646 | $397 |
| Novolog | 52 | $43,535 | $837 |
| Lantus | 75 | $42,724 | $570 |
| Novolin 70-30 | 62 | $27,423 | $442 |
| Prolia | 23 | $24,579 | $1,069 |
| Januvia | 28 | $22,227 | $794 |
| Humalog | 35 | $22,094 | $631 |
| Sensipar | 12 | $14,924 | $1,244 |
| Humulin 70-30 | 21 | $11,263 | $536 |
| Humalog Kwikpen U-100 | 13 | $9,475 | $729 |
| Vivelle-Dot | 11 | $9,338 | $849 |
| Victoza 2-Pak | 13 | $7,466 | $574 |
| Humalog Mix 75-25 Kwikpen | 12 | $7,041 | $587 |
| Ultra-Fine Mini Pen Needle | 91 | $6,832 | $75 |
| Tanzeum | 13 | $6,624 | $510 |
| Levothyroxine | 146 | $4,410 | $30 |
| Insulin | 84 | $3,126 | $37 |
| Ultra-Fine Short Pen Needle | 32 | $2,286 | $71 |
| Hydrocortisone | 35 | $1,827 | $52 |
| Desmopressin Acetate | 16 | $1,684 | $105 |
| Synthroid | 15 | $1,621 | $108 |
| Metformin | 101 | $996 | $10 |
| Methimazole | 57 | $902 | $16 |
| Insulin | 23 | $794 | $35 |
| Insulin | 14 | $717 | $51 |
| Glipizide | 65 | $656 | $10 |
| Fludrocortisone Acetate | 13 | $519 | $40 |
| Atorvastatin | 19 | $306 | $16 |
| Simvastatin | 38 | $264 | $7 |
| Alendronate | 26 | $226 | $9 |
| Amlodipine Besylate | 19 | $150 | $8 |
| Benazepril | 14 | $82 | $6 |
2016: 25 drugs
| Forteo | 21 | $52,060 | $2,479 |
| Lantus Solostar | 78 | $33,000 | $423 |
| Novolog Flexpen | 32 | $26,004 | $813 |
| Lantus | 42 | $23,199 | $552 |
| Humalog | 35 | $19,582 | $559 |
| Prolia | 15 | $14,599 | $973 |
| Novolin 70-30 | 22 | $13,020 | $592 |
| Novolog | 15 | $9,508 | $634 |
| Humalog Kwikpen U-100 | 13 | $6,823 | $525 |
| Levothyroxine | 136 | $4,119 | $30 |
| Bd Ultra-Fine Pen Needle | 53 | $3,210 | $61 |
| Insulin | 26 | $1,061 | $41 |
| Hydrocortisone | 13 | $867 | $67 |
| Metformin | 70 | $806 | $12 |
| Methimazole | 43 | $675 | $16 |
| Insulin | 16 | $527 | $33 |
| Glipizide | 42 | $465 | $11 |
| Alendronate | 33 | $309 | $9 |
| Atorvastatin | 20 | $306 | $15 |
| Fosinopril | 13 | $171 | $13 |
| Simvastatin | 25 | $111 | $4 |
| Benazepril | 14 | $95 | $7 |
| Metformin Hcl Er | 14 | $90 | $6 |
| Lisinopril | 12 | $82 | $7 |
| Amlodipine Besylate | 20 | $62 | $3 |
2015: 8 drugs
| Lantus Solostar | 18 | $6,862 | $381 |
| Levothyroxine | 116 | $3,303 | $28 |
| Hydrocortisone | 18 | $821 | $46 |
| Spironolactone | 15 | $483 | $32 |
| Methimazole | 47 | $386 | $8 |
| Alendronate | 19 | $270 | $14 |
| Simvastatin | 11 | $33 | $3 |
| Hydrochlorothiazide | 11 | $24 | $2 |
2014: 4 drugs
| Levothyroxine | 59 | $1,316 | $22 |
| Insulin | 13 | $467 | $36 |
| Methimazole | 34 | $358 | $11 |
| Alendronate | 20 | $262 | $13 |
2013: 2 drugs
| Levothyroxine | 26 | $482 | $19 |
| Methimazole | 16 | $271 | $17 |
Money from drug and device companies
$147 in 2020
| 2020 | 1 | 1 | None | $147 |
| 2019 | 1 | 3 | None | $115 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic MiniMed | Minimed 630g | $147 | 1 payment
|
See the published payment
| Medtronic MiniMed | Meals · 2020-01-10 | Minimed 630g | $147 |
See earlier years (2019)
2019: $115
| Novo Nordisk | None | $115 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1053569228
- Licence
- CA A110270California A110270: Current · expires 2027-08-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 2008
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 751 S Bascom Ave, Valley Specialty Center, Suite 210, San Jose, CA, 95128
- NPI first listed
- 2008-08-29
- NPI last updated
- 2013-10-29
This is when the NPI record was last certified, not a medical board exam.